Answers from the Lab

Ann Moyer, M.D., Ph.D., co-director of Mayo Clinic’s Molecular Technologies Laboratory, discusses Mayo Clinic Labs’ new focused pharmacogenomics panel. The test uses a real-time, PCR-based testing approach to perform geno- and phenotyping on 10 broadly applicable genes with known drug-gene associations to provide insight on patient response to a wide range of medications used in several medical specialities.

Show Notes

(00:31)
Dr. Moyer, could you provide us a little bit about you and your background?

(01:18)
 Would you mind sharing just a brief overview of the focus pharmacogenomics panel?
 
(03:32)
 So coming back to that patient focus, which patients should have this testing? And when do you recommend to be performed?
 
(05:17)
 Can you talk a little bit about what alternative test options are available and how they compare?
 
 (07:58)
 Can you comment on how the results from this test are used in patient care?
 
(11:55)
Any final thoughts you'd leave us with before we wrap up?

What is Answers from the Lab?

A Mayo Clinic curated podcast sharing Mayo Clinic knowledge and advancements on the state of testing, science, and people who are making it happen behind the scenes.